Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Deucravacitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 94,559Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Sotyktu

    02 2Sotyktu

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Sotyktu

    Deucravacitinib

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Sotyktu

    U.S.A
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Bristol Myers Squibb

    Deucravacitinib

    Main Therapeutic Indication : Immunology

    Currency : USD

    2022 Revenue in Millions : 8

    2021 Revenue in Millions : 0

    Growth (%) : New Launch in 2022

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Sotyktu

    Deucravacitinib

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Sotyktu

    U.S.A
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Bristol Myers Squibb

    Deucravacitinib

    Main Therapeutic Indication : Immunology

    Currency : USD

    2023 Revenue in Millions : 170

    2022 Revenue in Millions : 8

    Growth (%) : 2,025

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Sotyktu

    Deucravacitinib

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Sotyktu

    U.S.A
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Bristol Myers Squibb

    Deucravacitinib

    Main Therapeutic Indication : Immunology

    Currency : USD

    2024 Revenue in Millions : 246

    2023 Revenue in Millions : 170

    Growth (%) : 45

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF